Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial - Concepedia

Concepedia

Publication | Closed Access

Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial

41

Citations

17

References

2022

Year

Sarah Baker, Will Jiang, Benjamin Mou, C. Lund, Mitchell Liu, Alanah Bergman, Devin Schellenberg, Abraham Alexander, Hannah Carolan, Siavash Atrchian,

International Journal of Radiation Oncology*Biology*Physics

Local ControlProgression-free SurvivalOncologyMedicineSabr-5 TrialPharmacotherapyPharmacologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1